Pump position impacts heartmate II left ventricular assist device thrombosis

Ahmet Kilic, John Ransom, Simon Maltais, Benjamin Sun, John W. Entwistle, Stephen Bailey, Ranjit John, Charles T. Klodell, Igor Gregoric, Brett Sheridan, Joyce Chuang, David J. Farrar, Kartik Sundareswaran, Robert Adamson

Research output: Contribution to journalArticle

Abstract

The PREVENtion of HeartMate II pump Thrombosis through clinical management (PREVENT) study was a multicenter, prospective investigation to evaluate the rate of pump thrombosis (PT) with adoption of a uniform set of surgical and medical practices for left ventricular assist device implantation. We sought to quantify pump position at baseline and retrospectively define a pump position associated with poor clinical outcomes. Chest x-rays at baseline were prospectively obtained per protocol. Pump pocket depth, inflow cannula (IC) angle relative to the pump, and IC angle relative to the vertical were measured. Pumps falling in the tail-ends of the IC angle and pump pocket depth distributions were categorized as having an extreme pump position within the PREVENT study. Patients with extreme pump position had a significantly higher risk of confirmed and suspected PT, hemolysis, and elevated lactate dehydrogenase. In a multivariable analysis of survival free of confirmed PT, extreme pump position was an independent risk factor (hazard ratio = 3.6; 95% confidence interval = 1.5-8.9; p = 0.006) when adjusting for differences in pump speed and anticoagulation level. Our analysis shows that HeartMate II pump position at implant can significantly impact event-free survival and the incidence of adverse events at 6 months.

Original languageEnglish (US)
Pages (from-to)227-232
Number of pages6
JournalASAIO Journal
Volume65
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Thrombosis
Pumps
Accidental Falls
Survival Analysis
Hemolysis
L-Lactate Dehydrogenase
Disease-Free Survival
Thorax
X-Rays
Confidence Intervals
Incidence
Cannula

Keywords

  • HeartMate II
  • pump position
  • pump thrombosis

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

Kilic, A., Ransom, J., Maltais, S., Sun, B., Entwistle, J. W., Bailey, S., ... Adamson, R. (2019). Pump position impacts heartmate II left ventricular assist device thrombosis. ASAIO Journal, 65(3), 227-232. https://doi.org/10.1097/MAT.0000000000000840

Pump position impacts heartmate II left ventricular assist device thrombosis. / Kilic, Ahmet; Ransom, John; Maltais, Simon; Sun, Benjamin; Entwistle, John W.; Bailey, Stephen; John, Ranjit; Klodell, Charles T.; Gregoric, Igor; Sheridan, Brett; Chuang, Joyce; Farrar, David J.; Sundareswaran, Kartik; Adamson, Robert.

In: ASAIO Journal, Vol. 65, No. 3, 01.03.2019, p. 227-232.

Research output: Contribution to journalArticle

Kilic, A, Ransom, J, Maltais, S, Sun, B, Entwistle, JW, Bailey, S, John, R, Klodell, CT, Gregoric, I, Sheridan, B, Chuang, J, Farrar, DJ, Sundareswaran, K & Adamson, R 2019, 'Pump position impacts heartmate II left ventricular assist device thrombosis', ASAIO Journal, vol. 65, no. 3, pp. 227-232. https://doi.org/10.1097/MAT.0000000000000840
Kilic, Ahmet ; Ransom, John ; Maltais, Simon ; Sun, Benjamin ; Entwistle, John W. ; Bailey, Stephen ; John, Ranjit ; Klodell, Charles T. ; Gregoric, Igor ; Sheridan, Brett ; Chuang, Joyce ; Farrar, David J. ; Sundareswaran, Kartik ; Adamson, Robert. / Pump position impacts heartmate II left ventricular assist device thrombosis. In: ASAIO Journal. 2019 ; Vol. 65, No. 3. pp. 227-232.
@article{89ddc93dd1c94a43bf64ed394ee5a354,
title = "Pump position impacts heartmate II left ventricular assist device thrombosis",
abstract = "The PREVENtion of HeartMate II pump Thrombosis through clinical management (PREVENT) study was a multicenter, prospective investigation to evaluate the rate of pump thrombosis (PT) with adoption of a uniform set of surgical and medical practices for left ventricular assist device implantation. We sought to quantify pump position at baseline and retrospectively define a pump position associated with poor clinical outcomes. Chest x-rays at baseline were prospectively obtained per protocol. Pump pocket depth, inflow cannula (IC) angle relative to the pump, and IC angle relative to the vertical were measured. Pumps falling in the tail-ends of the IC angle and pump pocket depth distributions were categorized as having an extreme pump position within the PREVENT study. Patients with extreme pump position had a significantly higher risk of confirmed and suspected PT, hemolysis, and elevated lactate dehydrogenase. In a multivariable analysis of survival free of confirmed PT, extreme pump position was an independent risk factor (hazard ratio = 3.6; 95{\%} confidence interval = 1.5-8.9; p = 0.006) when adjusting for differences in pump speed and anticoagulation level. Our analysis shows that HeartMate II pump position at implant can significantly impact event-free survival and the incidence of adverse events at 6 months.",
keywords = "HeartMate II, pump position, pump thrombosis",
author = "Ahmet Kilic and John Ransom and Simon Maltais and Benjamin Sun and Entwistle, {John W.} and Stephen Bailey and Ranjit John and Klodell, {Charles T.} and Igor Gregoric and Brett Sheridan and Joyce Chuang and Farrar, {David J.} and Kartik Sundareswaran and Robert Adamson",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/MAT.0000000000000840",
language = "English (US)",
volume = "65",
pages = "227--232",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Pump position impacts heartmate II left ventricular assist device thrombosis

AU - Kilic, Ahmet

AU - Ransom, John

AU - Maltais, Simon

AU - Sun, Benjamin

AU - Entwistle, John W.

AU - Bailey, Stephen

AU - John, Ranjit

AU - Klodell, Charles T.

AU - Gregoric, Igor

AU - Sheridan, Brett

AU - Chuang, Joyce

AU - Farrar, David J.

AU - Sundareswaran, Kartik

AU - Adamson, Robert

PY - 2019/3/1

Y1 - 2019/3/1

N2 - The PREVENtion of HeartMate II pump Thrombosis through clinical management (PREVENT) study was a multicenter, prospective investigation to evaluate the rate of pump thrombosis (PT) with adoption of a uniform set of surgical and medical practices for left ventricular assist device implantation. We sought to quantify pump position at baseline and retrospectively define a pump position associated with poor clinical outcomes. Chest x-rays at baseline were prospectively obtained per protocol. Pump pocket depth, inflow cannula (IC) angle relative to the pump, and IC angle relative to the vertical were measured. Pumps falling in the tail-ends of the IC angle and pump pocket depth distributions were categorized as having an extreme pump position within the PREVENT study. Patients with extreme pump position had a significantly higher risk of confirmed and suspected PT, hemolysis, and elevated lactate dehydrogenase. In a multivariable analysis of survival free of confirmed PT, extreme pump position was an independent risk factor (hazard ratio = 3.6; 95% confidence interval = 1.5-8.9; p = 0.006) when adjusting for differences in pump speed and anticoagulation level. Our analysis shows that HeartMate II pump position at implant can significantly impact event-free survival and the incidence of adverse events at 6 months.

AB - The PREVENtion of HeartMate II pump Thrombosis through clinical management (PREVENT) study was a multicenter, prospective investigation to evaluate the rate of pump thrombosis (PT) with adoption of a uniform set of surgical and medical practices for left ventricular assist device implantation. We sought to quantify pump position at baseline and retrospectively define a pump position associated with poor clinical outcomes. Chest x-rays at baseline were prospectively obtained per protocol. Pump pocket depth, inflow cannula (IC) angle relative to the pump, and IC angle relative to the vertical were measured. Pumps falling in the tail-ends of the IC angle and pump pocket depth distributions were categorized as having an extreme pump position within the PREVENT study. Patients with extreme pump position had a significantly higher risk of confirmed and suspected PT, hemolysis, and elevated lactate dehydrogenase. In a multivariable analysis of survival free of confirmed PT, extreme pump position was an independent risk factor (hazard ratio = 3.6; 95% confidence interval = 1.5-8.9; p = 0.006) when adjusting for differences in pump speed and anticoagulation level. Our analysis shows that HeartMate II pump position at implant can significantly impact event-free survival and the incidence of adverse events at 6 months.

KW - HeartMate II

KW - pump position

KW - pump thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85064856285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064856285&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000840

DO - 10.1097/MAT.0000000000000840

M3 - Article

VL - 65

SP - 227

EP - 232

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -